首页> 外国专利> DIAGNOSTIC TECHNIQUE FOR GENETIC PREDISPOSITION TO ISCHEMIC STROKE DEVELOPMENT IN PATIENTS WITH ATRIAL FIBRILLATION

DIAGNOSTIC TECHNIQUE FOR GENETIC PREDISPOSITION TO ISCHEMIC STROKE DEVELOPMENT IN PATIENTS WITH ATRIAL FIBRILLATION

机译:房颤患者遗传性缺血性卒中易发性的诊断技术

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine and concerns genetic predisposition to risk of ischemic stroke developing diagnostic technique in patients with atrial fibrillation (AF). Method summary: performing analysis of hemostasis system genes: polymorphism -455GA of FBG gene, polymorphism 10976GA of FVII gene, polymorphism -5TC of GPIβα gene, polymorphism 807CT of GPIα gene. At that, assigned with 0 %, upon detecting of GG polymorphism -455GA of FBG gene, AA polymorphism 10976GA of FVII gene, TT polymorphism -5TC of GPIβα gene, CC polymorphism 807CT of GPIα gene. Assigned with 50% upon detecting of GA polymorphism -455GA of FBG gene, GA polymorphism 10976GA of FVII gene, TC polymorphism -5TC of GPIβα gene, CT polymorphism 807CT of GPIα gene. Assigned with 100 % upon detecting of AA polymorphism -455GA of FBG gene, GG polymorphism 10976GA of FVII gene, CC polymorphism -5TC of GPIβα gene, TT polymorphism 807CT of GPIα gene. Genetic risk of ischemic stroke development with AF is calculated by formula: (a+b+c+d)/n, where a is percentage corresponding to polymorphism genotype -455G A of FBG gene, b is percentage corresponding to polymorphism genotype 10976GA of FVII gene, c is percentage corresponding to polymorphism genotype -5TC of GPIβα gene, d is percentage corresponding to polymorphism genotype 807CT of GPIα gene, n is number of studied genotypes; risk is considered to be low at value from 0 to 30 %, average is from 30 to 60 %, high is from 60 % and more.;EFFECT: proposed method allows to highlight genetic risk of ischemic stroke development in presence of AF in patient and increase ischemic stroke developing individual prevention quality in given group of patients.;1 cl, 5 dwg, 5 tbl, 2 ex
机译:领域:药物:本发明涉及药物并且涉及遗传学上的倾向,以用于房颤(AF)患者的缺血性中风发展诊断技术的风险。方法总结:对止血系统基因进行分析:FBG基因多态性-455G> A,FVII基因多态性10976G> A,GPIβα基因多态性-5T> C,GPIα基因多态性807C> T。此时,当检测到FBG基因的GG多态性-455G> A,FVII基因的AA多态性10976G> A,GPIβα基因的TT多态性-5T> C,CC多态性807C>GPIα基因的T时,指定为0%。检测到FBG基因的GA多态性-455G> A,FVII基因的GA多态性10976G> A,GPIβα基因的TC多态性-5T> C,CT多态性807C>GPIα基因的T时,分配为50%。检测到FBG基因的AA多态性-455G> A,FVII基因的GG多态性10976G> A,GPIβα基因的CC多态性-5T> C,GPIα基因的TT多态性为100%。 AF导致缺血性中风发展的遗传风险可通过以下公式计算:(a + b + c + d)/ n,其中a是对应于FBG基因多态性基因型-455G> A的百分比,b是对应于多态性基因型10976G>的百分比FVII基因的A,c为与GPIβα基因的多态性基因型-5T> C相对应的百分比,d为与GPIα基因的多态性基因型807C> T相对应的百分比,n为所研究的基因型数。风险被认为是低值,从0%到30%,平均从30%到60%,高从60%甚至更高。;效果:提出的方法可以突出显示患者房颤存在时缺血性中风发展的遗传风险并增加特定组患者的缺血性卒中发展个人预防质量。; 1 cl,5 dwg,5 tbl,2 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号